The Indian market for GLP-1 drugs is yet to open up fully due to the unavailability ... According to Novo Nordisk’s website, ...

Patients taking Ozempic and other trendy injectables are going ... limitations in microdosing weight-loss medications, she ...

While “microdosing Ozempic” joins the lexicon on ... she said. Brand-name GLP-1 medications come in fixed-dose pen injectors, making personalized dose adjustments impossible.

A new stronger Ozempic is coming. Here’s what to knowNovo Nordisk (NVO) teased some new details about a potential Ozempic ...

With Ozempic, your pen may contain four or eight doses ... A large review of studies compared GLP-1 agonist medications, including semaglutide, for lowering people’s risk of cardiovascular ...

It is thought to be the first death in the UK linked to the medication Mounjaro, nicknamed the ‘King Kong jab’ ...

Let us look at five large biotech and generic drug companies, NVO, GILD, MRNA, VTRS and TEVA, which are gearing up for their ...

Following a disappointing earnings showing from Eli Lilly last week, Novo Nordisk’s latest report on the performance of its ...

You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists ...

There's a new player in the running game, and it's not the latest carbon-plated shoe or fancy GPS watch. GLP-1 medications ...